Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Valsartan for Prevention of Recurrent Atrial Fibrillation
New England Journal of Medicine, 04/16/09
Atrial fibrillation is the most common cardiac arrhythmia, and no current therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II–receptor blockers (ARBs) can influence atrial remodeling, and some clinical studies suggest that they may prevent atrial fibrillation. Treatment with valsartan was not associated with a reduction in the incidence of recurrent atrial fibrillation.
Related Articles
Atrial Fibrillatory Wall Motion and Degree of Atrial Remodeling in Patients with Atrial Fibrillation: A Tissue Velocity Imaging Study
Journal of Cardiovascular Electrophysiology, 10/28/09
Relevance Score: 70%
Catheter Ablation of Supraventricular Arrhythmias and Atrial Fibrillation
American Family Physician, 11/12/09
Relevance Score: 69%
Sudden atrial fibrillation associated with acute alcohol ingestion and cor triatriatum
Baylor UMC Proceedings, 10/27/09
Relevance Score: 69%
Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrillation
Evidence-Based Medicine, 10/26/09
Relevance Score: 69%
Glucocorticoid Use and Risk of Atrial Fibrillation or Flutter
Archives of Internal Medicine, 10/14/09
Relevance Score: 69%
Today in Arrhythmias/EP...keeping you current
Receive free subspecialty "5-minute updates" via email
Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity
Heart Rhythm, 12/11/09
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post–myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF
Heart Rhythm, 12/11/09
Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease
Heart Rhythm, 12/11/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Doxorubicin Cardiomyopathy
Cardiology, 12/11/09
Valsartan plus hydrochlorothiazide for first-line therapy in hypertension
Expert Review of Cardiovascular Therapy , 12/11/09
Perioperative Intravenous Amiodarone Does Not Reduce the Burden of Atrial Fibrillation in Patients Undergoing Cardiac Valvular Surgery
Anesthesiology, 12/10/09
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3',5'-Cyclic Monophosphate–Dependent Pathway
Hypertension, 12/10/09
The Enhancing Secondary Prevention in Coronary Artery Disease trial
Canadian Medical Association Journal, 12/10/09
Daily consumption of milk enriched with fish oil, oleic acid, minerals and vitamins reduces cell adhesion molecules in healthy children
Nutrition, Metabolism & Cardiovascular Diseases, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


